Genmab — Februar 2024

[E_L]

Kesimpta, tepezza, tisotumab, talquetamab, teclistamab, amivantamab, these are not little drugs. the technology is there. But there is nobody that can guarantee a repeat, that is true.

[JørgenVarnæs]

...with how much ownership? GEN is being traded as a bond with the royalties from dara and the cash holding as a foundation. Other than that, there is very little of value in the valuation

[JørgenVarnæs]

KYSO must be about how much value GEN leaves on the table for the partners

[E_L]

which is why they want 50/50 partnerships in the future. which they hope to get from the stronger position they are in now. beter deals were not possible in the past , unfortunately

[JørgenVarnæs]

Better deals were possible every step of the way

[JørgenVarnæs]

GEN hasn't missed one single step in messing up values

[Sukkeralf]

I think you are unbelievable harsh in your criticism of Genmab JV - its still one of the most successful biotechs in Europe

[JørgenVarnæs]

Seriously - take out dara and cash from the valuation and you are left with dust and tubleweeds. Is that the hallmark of a successful R&D organization?

[JørgenVarnæs]

Its time GEN starts earning its keep for the shareholders

[Bulder]

You cannot put a finger on the Scientific side of genmab. It’s been an unprecedented world class succes. Their wiilingness to pay out to shareholders however is far from satisfying.

[JørgenVarnæs]

Please note, that I'm not questioning the quality of the research - I'm questioning the business decisions following the research

[JørgenVarnæs]

Am I completely wrong in saying, that the current GEN valuation is made up ENTIRELY from cash and expected dara-derived royalties?

[Bulder]

Genmab is not to be blamed for the current Price. It’s not Long ago it was +3000. Business hasn’t changed since then.

[JørgenVarnæs]

No? I beg to differ

[JørgenVarnæs]

When Verdult says he still has respect for GEN leadership - but dara has been gifted to the partner and hexacd38 is closed country, he is really saying - there is not much respect left

[E_L]

GEN1046 Safety Trial has gone from Recruiting -to - Active, not recruiting https://classic.clinicaltrials.gov/ct2/history/NCT03917381?A=26&B=27&C=merged#StudyPageTop

[Teller]

To be honest - My greatest concern is the deal made on super Dara. Was the same lawyers used for this deal??

[w]

i asked Carlsen about this, regarding a sub version

[w]

Hi Martin,
Hexabody CD38 is currently intravenous but can be made to SC by JnJ

[Teller]

You not only have to be a good scientist and be able to develop new and wonderful drugs. You also and importantly have to be extremely "Street-smart" in a legal sense.